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1  | INTRODUC TION
Cocirculation of distinct influenza types, subtypes, and strains has 
allowed for rare coincidental infection with more than one type or 
subtype of influenza.1-3 In addition, consecutive infection with influ-
enza A and B viruses within a single season has been demonstrated.4 
Recurrent within-season influenza A (H1N1) infections have also been 
reported for two immunocompetent, but high-risk patients.5 Here, we 
report a unique case of two sequential, within-season infections with 
highly similar influenza A (H3N2) viruses in a usually healthy vacci-
nated child.
2  | METHODS
This case was identified within a community-based research study, oc-
curring outside of medical care settings. Briefly, since January 5, 2015, 
a longitudinal school-based influenza surveillance study has been on-
going at the Oregon School District (OSD) in South Central Wisconsin. 
ORCHARDS (ORegon CHild Absenteeism due to Respiratory Disease 
Study) is designed to assess the utility of school absenteeism monitor-
ing for early influenza outbreak detection by comparing illness-related 
absenteeism with medically attended influenza in surrounding com-
munities. Parents of children with influenza-like illness (ILI) symptoms 
voluntarily call a study hotline; students are screened for ILI crite-
ria and, if eligible, receive a home visit from a research team mem-
ber. Research staff collect nasal and naso/oropharyngeal (NP/OP) 
specimens along with symptom and epidemiologic data. Specimens 
are tested by rapid influenza diagnostic testing (RIDT; Quidel Sofia 
Influenza A + B FIA) within 2 hours of the home visit.
All specimens are then tested for influenza by rRT-PCR (IVD CDC 
Human Influenza Virus RT-PCR Diagnostic Panel) and other respi-
ratory viruses (Luminex NxTAG Respiratory Pathogen Panel: RPP) 
at the Wisconsin State Laboratory of Hygiene (WSLH). The WSLH 
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Abstract
Cocirculation of varying influenza types, strains, and lineages allows coinfection and 
intra-season sequential infection, although a same-strain sequential infection has 
not been previously described. This case report describes the first known case of 
sequential laboratory-confirmed influenza A (H3N2) infections in a child within one 
season.
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undergoes a rigorous validation process for diagnostic tests, includ-
ing rRT-PCR, in accordance with federal CLIA licensing standards. 
Unidirectional workflow, preparing aliquots of one specimen at a time, 
dedicated specimen processing equipment and laboratory area, and 
decontamination of biosafety cabinet (BSC) and laboratory benches 
after each use ensure cross-contamination risks are minimized.
Beginning in September 2016, families of ORCHARDS subjects 
were invited to participate in a home transmission substudy, for 
which nasal swabs are obtained from family members the day of the 
visit (day 0) and 7 days later, along with a day 7 nasal swab from the 
ORCHARDS subject. All specimens from household members are 
tested for influenza using rRT-PCR as above.
Exceptionally for this case study, next-generation genome se-
quencing was performed at WSLH using the Illumina MiSeq™ platform. 
Sequence reads were trimmed using Trimmomatic with a 4-bp sliding 
window quality score cutoff of Q30.6 For both samples, we mapped 
the trimmed sequence reads against a vaccine strain HA reference 
sequence A/Hong Kong/4801/2014 using Geneious version 11.0.5.7
The University of Wisconsin Institutional Review Board (IRB) 
(2013-1357-CP022) approved the study protocol, and the Centers for 
Disease Control and Prevention's Human Research Protection Office 
reviewed and approved deferral to the University of Wisconsin's IRB.
3  | C A SE PRESENTATION
3.1 | Episode 1
On January 31, 2018, a usually healthy, 9-year old, non-Hispanic 
white female was screened for ORCHARDS eligibility (Figure 1). 
She was a vaccinated (quadrivalent inactivated influenza vaccine 
on October 9, 2017) 4th-grade student who lived with both par-
ents and two younger siblings. All family members had received the 
2017/2018 influenza vaccine. A home visit was conducted 25 hours 
after symptom onset. Her moderate ILI was characterized by fever 
(measured temperature = 37.2°C after antipyretic), chills, cough, 
sore throat, rhinorrhea, nasal congestion, headache, malaise, myal-
gia, anorexia, and sneezing. There was no recent travel, exposure to 
farm animals, or identified sick contact preceding onset. Nasal and 
oropharyngeal specimens were collected. Although the RIDT result 
was negative, rRT-PCR was positive for influenza A (H3N2) (cycle 
threshold value [Ct] = 31.48) and RPP was positive for coronavirus 
HKU1. At follow-up, she reported 2 days of absenteeism and con-
tinued cough, rhinorrhea, sore throat, myalgia, and headache. There 
had been no medical follow-up or antiviral treatment. The rRT-PCR 
result from the subject's day 7 swab was negative for influenza. No 
other family members reported illness on day 0, but one sibling de-
veloped mild respiratory illness on day 6. All family members tested 
negative for influenza by rRT-PCR on day 0 and day 7.
3.2 | Episode 2
On March 9, 2018, 37 days after the initial encounter, the subject was 
again screened due to a new ILI episode. A home visit was conducted 
49 hours after symptom onset. Now 10 years old, the subject com-
plained of significant symptoms including fever (measured tem-
perature = 37.6°C after antipyretic), chills, cough, wheezing, nasal 
F I G U R E  1   Timeline of events related to two sequential episodes 
of influenza A (H3N2) in a previously healthy, 4th-grade child. (PCR, 
polymerase chain reaction; RIDT, rapid influenza diagnostic test; 
RPP, respiratory pathogen panel)
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congestion, headache, malaise, myalgia, anorexia, burning eyes, and 
dizziness. Again, there was no recent travel, exposure to farm ani-
mals, or identified sick contact preceding onset. The subject's RIDT 
result was positive for influenza A, and rRT-PCR results confirmed 
the presence of influenza A (H3N2) (Ct = 26.48). At follow-up, she 
reported 2 days of absenteeism and continued fever, chills, cough, 
rhinorrhea, malaise, myalgia, headache, and anorexia. There had 
been no medical follow-up or antiviral treatment. The rRT-PCR re-
sults from the subject's day 7 swab continued to show influenza A 
(H3N2) (Ct = 33.30). No other family members reported illness on 
day 0 or day 7. All family members tested negative for influenza by 
rRT-PCR on day 0 and day 7.
3.3 | Whole‐genome sequencing
The subject's initial specimen from each episode, collected on 
January 31 and March 9, 2018, was prepared for full genomic 
sequencing at the WSLH. Both A (H3N2) strains were of the he-
magglutinin gene clade 3C2.a2. After WSLH performed a con-
sensus sequence comparison between the two viruses collected 
from the subject, three single nucleotide polymorphisms (SNPs) 
were identified within the coding region of the HA protein. Only 
one SNP was non-synonymous and resulted in an isoleucine to 
leucine change at position 67 (in HA1). This particular polymor-
phism was near 100% frequency in the sequence reads and was 
four amino acids away from an established antibody epitope site 
(Site E).8 Both sequences (first isolate ORCH00001 and second 
isolate ORCH00002) were submitted to the GenBank® genetic 
sequence database and given accession numbers (MK262897 and 
MK262898, respectively).
4  | DISCUSSION
This is the first known case of two sequential, within-season infec-
tions with influenza A (H3N2). Moreover, this case occurred within 
an immunocompetent and fully vaccinated child. The period be-
tween ILI episodes (37 days), the absence of influenza by PCR at 7-
day follow-up of the first episode, the resolution of symptoms, and 
the development of a new ILI support two distinct episodes of influ-
enza infection.
In the first episode, coinfection with coronavirus HKU1 was 
documented as well as a high Ct value for influenza A (H3N2) and 
a falsely negative RIDT. This may imply a relatively low viral load 
and possible immune interference induced by coinfection with coro-
navirus.9 Although the estimated vaccine effectiveness during the 
2017‐2018 influenza season was low at 17% (95% CI: −14 to 40), 
the seasonal vaccine may have offered some partial protection.10-12
In the second episode, the subject's ILI was more significant, 
the RIDT was positive, and her initial specimen manifested a much 
lower Ct value, implying a higher viral load. This occurred despite 
vaccine receipt and prior infection with the same influenza sub-
type. The timing of the first episode, relative to the second, was 
such that neutralizing antibodies should have been present.13 
Although the two viruses were genetically similar and clustered 
with other viruses that circulated within the community, it is pos-
sible that the I67L polymorphism could impart a structural change 
affecting antibody recognition. This case suggests that an influ-
enza virus can evade the immune response of an immunocom-
petent, vaccinated child who was recently infected with a similar 
virus.
It is known that influenza remains under-detected by established 
surveillance systems, which rely on sentinel-based reporting of med-
ically attended cases.13 This case demonstrates the intrinsic value of 
longitudinal studies of influenza within communities coupled with 
laboratory support that can provide antigenic characterization and 
genomic sequencing. A focus on medically attended influenza would 
have missed this case. Cocirculation of clade 3C2.a2 variants within 
a single community causing reinfection may offer a possible expla-
nation for the prolonged and intense influenza season experienced 
in 2017-2018. Further assessments are needed to assess the fre-
quency of within-season reinfection with influenza A (H3N2).
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